RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Stock-based compensation

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.5B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 202419-19.74%
Dec 31, 202323-1.69%
Dec 31, 202224-36.80%
Dec 31, 202138+10.29%
Dec 31, 202034+39.34%
Dec 31, 201924+61.59%
Dec 31, 201815-6.21%
Dec 31, 201716-17.44%
Dec 31, 201620-34.12%
Dec 31, 201530+59.14%
Dec 31, 201419-12.26%
Dec 31, 201321+36.77%
Dec 31, 201216+98.72%
Dec 31, 20108

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)